34
Views
2
CrossRef citations to date
0
Altmetric
Original Paper

Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact

&
Pages 377-390 | Published online: 07 Jul 2009

References

  • Lowder JN, Herzig RH. The storage and processing of bone marrow for transplantation. In: Dutcher J, editor. Modern transfusion therapy. Vol. II. Boca Raton, FL: CRC Press, Inc. 1989:201–11.
  • Goldman M, Blajchman MA. Blood product-associated bacterial sepsis. Transfus Med Rev 1991;5:73— 83.
  • Stroncek DF, Fautsch SK, Laskey LC et al. Adverse reactions inpatients transfused with cryopreserved marrow. Transfusion 1991;31:521–6.
  • Attarian H, Bensinger WI, Buckner CD et al. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996;17:699— 702.
  • Lazarus HM, Magalhaes-Silverman M, Fox RM et al. Contam-ination during in vitro processing of bone marrow for trans-plantation: clinical significance. Bone Marrow Transplant 1991;7:241— 6.
  • Espinosa MTF, Fox R, Creger RJ, Lazarus HM. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion 1996;36:789–93.
  • Schwella N, Zimmerman R, Heuft HG et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 1994;67:32— 5.
  • Prince HM, Page SR, Keating A et al. Microbial contaminationof harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995;15:87— 91.
  • Yawn DH. Properties of salvaged blood. In: Taswell HF, PinedaAA, editors. Autologous transfusion and hemotherapy. Boston: Black-well Scientific Publications, 1991: 194–206.
  • Schepers KG, Davis JM, Rowley SD. Incidence of bacterial contamination of bone marrow grafts. In: Gee A, Gross S, Worthington-White D, editors. Advances in bone marrow purging and processing. New York: Wiley-Liss, 1992: 379— 84.
  • Padley D, Koontz F, Trig ME et al. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996;36:53— 6.
  • Barrett BB, Andersen JW, Andersen KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993;33:228— 33.
  • Buchholz DH, Young VM, Friedman NR et al. Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion 1973;13:268–75.
  • Nasser RM, Hajjar I, Sandhaus LM et al. Routine cultures of bone marrow and peripheral stem cell harvests. Clinical impact, cost analysis, and review. Clin Infect Dis 1998;27:886— 8.
  • Rowley SD, Davis JM, Dick J et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation:incidence and clinical significance. Transfusion 1988;28:109— 12.
  • Mermel LA, Maki DG. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993;119:270–2.
  • Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001;33:947— 53.
  • Engels EA, Ellis CA, Supran SE, et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 199;28:256–66.
  • Winston DJ, Gale RP, Meyer DV, Young LS. Infectious complications of human bone marrow transplantation. Med (Baltimore) 1979;58:1— 31.
  • Lowder JN, Lazarus HM, Herzig RH. Bacteremias and fungemias in onco logic patients with central venous catheters: changing spectrum of infection. Arch Intern Med 1982;142:1456–9.
  • Schwella N, Rick 0, Heuft HG et al. Bacterial contamination ofautologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the post-transplanta-tion course. Vox Sang 1998;74: 88–94.
  • Smith D, Bradley, Scott GM. Bacterial contamination of autologous bone marrow during processing. 7 Hosp Infect 1996;33: 71–6.
  • Arnow PM, Houchins SG, Richards JM, Chudy R. Aspergillusfumigarus contamination of lymphokine-activated killer cells infused into cancer patients. 7 Gun Microbiol 1991;29:1038–41.
  • Chapin-Robertson K, Dahlberg SE, Edberg SC. Clinical and laboratory analyses of cytospin-prepared Gram stains for recovery and diagnosis of bacteria from sterile body fluids. Clin Microbiol 1992;30:377–80.
  • Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influen-cing prognosis. Rev Infect Dis 1983;5:54— 70.
  • Lazarus HM, Lowder JN, Anderson JM, Herzig RH. A prospective randomized trial of central venous catheter removal versus intravenous Amphotericin B in febrile neutropenic patients. 7 Parenter Enteral Nutr 1984;8:501— 5.
  • Wang CC, Mattson D, Wald A. Counebacterium jeikeium bacter-mia in bone marrow transplant patients with Hickman catheters. Bone Marrow Transplant 2001;27:445–9.
  • Bow EJ, Rayner E, Louie TJ. Comparison of norfloxacin with cotrimoxazole for infectious prophylaxis in acute leukemia. Am Med 1988;84:847— 54.
  • Pizzo PA, Hathorn JW, Hiemenz J et al. A randomized trial comparing ceftazidime alone with combination antibiotic ther-apy in cancer patients with fever and neutropenia. N Engl Med 1986;315:552–8.
  • Henslee J, Kenyon P, Ferreiri P et al. Prevention of early Grampositive septicemia in autologous bone marrow transplant patients [Abstract]. Proc Am Soc Clin Oncol 1984;3:100.
  • Somekh E, Douer D, Shaked N, Rubinstein E. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progentiro cells and on leukemic cell lines. Pharm Exp Ther 1989;248:415–8.
  • Rahman MU, Mazumder A. The immunomodulatory effects of gentamicin, imipenem piperacillin and amphotericin B on LAK effector function in vitro. Immunol Med Microbiol 2001;30:249— 52.
  • Cottell E, Lennon B, McMorrow J et al. Procesing of semen in anantibiotic-rich culture medium to minimize microbial presence during in vitro fertilization. Fertil Steril 1997;67:98— 103.
  • Gopinathan U, Reddy MK, Nadkarni MS et al. Antimicrobial effect of ciprofloxacin, povidone-iodine and gentamicin in the decontamination of human donor globes. Cornea 1998;17:57–61.
  • Hooe W, Steinberg B. Management of contaminated bone grafts:an experimental in vitro study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:34— 7.
  • Cooper De, Arnoczky SP, Warren RE Contaminated patellar tendon grafts: incidence of positive cultures and efficacy of an antibiotic solution — an in vitro study. Arthroscopy 1991;7:272–4.
  • Kaplan A. Anaphylaxis. In: Bennett HC, Plum E Cecil textbook of medicine. 20th edn, Philadelphia: W.B. Saunders, 1996:1414–20.
  • Arozullah AM, Khuri SF', Henderson WG, Daley J. Develop-ment and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 2001;135:847–57.
  • Elishoov H, Or R, Strauss N, Engelhard D. Nosocomial colonization, septicemia and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Med (Baltimore) 1998;77: 83— 101.
  • Ulz L, Petersen FB, Ford R et al. A prospective study of complications in Hickman right-atrial catheters in marrow transplant patients. 7 Parenter Enteral Nutr 1990;14:27— 30.
  • Deeg HJ, Amylon ID, Harris RE et al. Marrow transplants fromunrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant 2001;7:208— 15.
  • Zaza S, Tokars JI, Yomtovian R et al. Bacterial contamination ofplatelets at a university hospital: increased identification due to intensified surveillance. Infect Control Hosp Epidemiol 1994;15:82–7.
  • Gerber A, Struy H, Weiss G et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients. 7 Interferon Cytokine Res 2000;20:1083–90.
  • Carulli G. Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions. Haematologica 1997;82:606— 12.
  • Recommendations of CDC, Infectious Diseases Society of America and the American Society of Blood and Marrow Transplantation: Guidelines for preventing opportunistic infec-tions among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6:659— 734.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.